Previous Editions
- Browse previous editions and archived issues of BJLM below
- Check back again soon for more
- Check back again soon for more
- Check back again soon for more
Evidence. Excellence. Education.
British Journal of Longevity Medicine
The British Journal of Longevity Medicine (BJLM) is BILM’s open-access journal dedicated to advancing the science, clinical practice and professional standards of longevity medicine, preventive medicine and regenerative health.
BJLM publishes peer-reviewed work that helps clinicians, researchers and industry partners better understand the evidence behind interventions, biomarkers, diagnostics and service models that aim to improve healthspan.
BJLM is overseen by an editorial team made up of research scientists, academic clinicians and physicians with expertise in longevity medicine. Their combined experience ensures that the journal maintains high scientific standards, clinically relevant content and a rigorous peer-review process that reflects the evolving evidence base in the field.
About the journal
BJLM is designed to be a trusted academic home for high-quality longevity medicine scholarship in the UK and beyond. It provides a platform for original research, reviews, clinical perspectives, consensus statements, service evaluations and educational articles relevant to doctors working in longevity and related fields.
The journal supports BILM’s broader mission to promote evidence-based practice, raise standards and help shape the future of longevity medicine as a serious clinical discipline.
What we publish
- BJLM Welcomes
- Original research
- Systematic and narrative reviews
- Clinical and translational studies
- Service evaluations
- Case series and case reports
- Consensus statements and position papers
- Editorials and commentaries
- Educational and methods articles
FOR AUTHORS
Authors are invited to submit manuscripts for consideration via the BJLM for Authors page where further information is available.
BJLM is open access, meaning published articles are freely available to read online. Authors retain visibility and reach, while readers benefit from unrestricted access to current work in longevity medicine.
Why BJLM matters
Longevity medicine is a rapidly developing field, but the quality of evidence is uneven. The british jorurnal of longevity medicine exists to help close that gap by publishing rigorous, clinically relevant work that can inform practice, policy and future research. For clinicians, BJLM offers a way to stay informed. For researchers, it offers a credible route to publication. For the wider field, it helps build a stronger evidence base for longevity medicine in the UK.